Publication | Closed Access

Interferon alpha-2a Plus Ribavirin 1,000/1,200 mg versus Interferon alpha-2a Plus Ribavirin 600 mg for Chronic Hepatitis C Infection in Patients on Opiate Maintenance Treatment: An Open-Label Randomized Multicenter Trial

HepatologyViral HepatitisMedicineAntiviral TherapyHepatitisTreatment OptionAddiction MedicinePharmacotherapyAntiviral DrugDrug TreatmentOpiate Maintenance TreatmentPharmacology